Some of Excel’s most powerful modern features simply do not work inside tables. Dynamic array formulas, often called spill ...

The global compounding pharmacy market size is expected to be worth nearly USD 31.77 billion by 2034, increasing from USD 18.02 billion in 2025 and it is growing at a compound annual growth rate (CAGR ...

Note: Compounded drugs are not approved by theU.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. Despite new rules limiting their manufacture, compounded ...

The new Premix facility in North Carolina with carbon black silos visible on the outside. Premix's new facility in North Carolina features end-to-end automation to provide real-time monitoring of ...

Cars parked in the Towers parking lot at the University of Connecticut. Parking has increasingly become an issue as the university has overenrolled. Photo courtesy of Colin Mitchell/The Daily Campus ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Loan Calc lets you compute monthly payments, total interest, and repayment schedules for loans or mortgages with various compounding options. Loan Calc is a user-friendly macOS app designed for anyone ...

Pulse starts with 13% APR on Arbitrum’s Ethereum PT markets. The agent eliminates manual tracking with 24/7 portfolio building, rebalancing, and management. PENDLE has gained more than 7% amid the ...

The FDA has received hundreds of adverse event reports after people used compounded GLP-1 drugs for weight loss. Compounded GLP-1 drugs aren’t reviewed by the FDA for safety or effectiveness. The FDA ...

Please provide your email address to receive an email when new articles are posted on . Speakers at a congressional briefing highlighted safety concerns around counterfeit GLP-1 drugs. A white paper ...

Flush with funding and surging demand, compounding pharmacies are attracting capital from private equity firms, venture capital firms, and hospitals, reshaping the pharmaceutical power dynamic from ...